---
type: "NewsArticle"
title: "Probiotic trial in early cognitive impairment examines cognition and tau markers"
description: "A 24-week randomized trial in 87 people with early cognitive impairment found lower pTau181 and selective visuospatial signals, but no MMSE, verbal-memory or executive-score difference."
resource: "https://nootropikler.com/news/multistrain-probiotics-early-cognitive-impairment"
tags: ["nutrition", "cognition", "research"]
timestamp: 2026-10-04T23:57:55Z
language: "en"
---

# Probiotic trial in early cognitive impairment examines cognition and tau markers

A 24-week randomized trial in 87 people with early cognitive impairment found lower pTau181 and selective visuospatial signals, but no MMSE, verbal-memory or executive-score difference.

Author: Nootropik News Editorial Team
Published: 2026-10-04T23:57:55Z
Update: 2026-10-04T23:57:55Z
News/source date: 2026-08-28
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

This double-blind, placebo-controlled trial randomized 87 older adults with early cognitive impairment to a multistrain probiotic (n=40) or placebo (n=47) for 24 weeks. Measures included plasma pTau181, GFAP and neurofilament light, along with CDR-SB, CERAD, Stroop and Rey-Osterrieth Complex Figure tests.

## Findings

Compared with placebo, the probiotic group had lower plasma pTau181 (p&lt;0.001) and improved CDR-SB scores (p=0.010), mainly in the memory domain. Two visuospatial construction measures improved and constructional recall was preserved. No significant between-group differences appeared in MMSE, verbal memory or executive scores.

## Limitations and disclosures

The sample and follow-up are too small and short to establish durable clinical benefit or broad generalizability. Biomarker change does not by itself establish meaningful daily-life benefit, and the cognitive findings were selective. Independent trials are needed to test replication and this specific formulation.

## Sources

- [Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial](https://doi.org/10.1177/13872877261477084) — 2026-08-28
